1. Home
  2. OLMA vs QLYS Comparison

OLMA vs QLYS Comparison

Compare OLMA & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • QLYS
  • Stock Information
  • Founded
  • OLMA 2006
  • QLYS 1999
  • Country
  • OLMA United States
  • QLYS United States
  • Employees
  • OLMA N/A
  • QLYS N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • QLYS Computer Software: Prepackaged Software
  • Sector
  • OLMA Health Care
  • QLYS Technology
  • Exchange
  • OLMA Nasdaq
  • QLYS Nasdaq
  • Market Cap
  • OLMA 465.4M
  • QLYS 5.7B
  • IPO Year
  • OLMA 2020
  • QLYS 2012
  • Fundamental
  • Price
  • OLMA $6.10
  • QLYS $140.73
  • Analyst Decision
  • OLMA Strong Buy
  • QLYS Hold
  • Analyst Count
  • OLMA 5
  • QLYS 18
  • Target Price
  • OLMA $26.25
  • QLYS $154.19
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • QLYS 298.7K
  • Earning Date
  • OLMA 11-12-2024
  • QLYS 02-05-2025
  • Dividend Yield
  • OLMA N/A
  • QLYS N/A
  • EPS Growth
  • OLMA N/A
  • QLYS 22.85
  • EPS
  • OLMA N/A
  • QLYS 4.53
  • Revenue
  • OLMA N/A
  • QLYS $592,950,000.00
  • Revenue This Year
  • OLMA N/A
  • QLYS $11.24
  • Revenue Next Year
  • OLMA N/A
  • QLYS $7.62
  • P/E Ratio
  • OLMA N/A
  • QLYS $31.07
  • Revenue Growth
  • OLMA N/A
  • QLYS 9.66
  • 52 Week Low
  • OLMA $5.56
  • QLYS $119.17
  • 52 Week High
  • OLMA $16.78
  • QLYS $206.25
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • QLYS 38.20
  • Support Level
  • OLMA $5.56
  • QLYS $140.19
  • Resistance Level
  • OLMA $6.87
  • QLYS $159.73
  • Average True Range (ATR)
  • OLMA 0.81
  • QLYS 3.45
  • MACD
  • OLMA -0.28
  • QLYS -2.42
  • Stochastic Oscillator
  • OLMA 10.12
  • QLYS 2.76

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About QLYS Qualys Inc.

Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.

Share on Social Networks: